Publication:
Screening for fabry disease in patients who underwent renal biopsy and identification of a novel mutation

dc.contributor.authorOruç, Ayşegül
dc.contributor.authorYıldız, Abdulmecit
dc.contributor.authorAkgür, Suat
dc.contributor.authorAydın, Mehmet Fethullah
dc.contributor.authorErsoy, Alparslan
dc.contributor.authorYavuz, Mahmut
dc.contributor.authorDilek, Kamil
dc.contributor.authorGüllülü, Mustafa
dc.contributor.buuauthorORUÇ, AYŞEGÜL
dc.contributor.buuauthorYILDIZ, ABDULMECİT
dc.contributor.buuauthorAKGÜR, SUAT
dc.contributor.buuauthorAydın, Mehmet Fethullah
dc.contributor.buuauthorERSOY, ALPARSLAN
dc.contributor.buuauthorYAVUZ, MAHMUT
dc.contributor.buuauthorDİLEK, KAMİL
dc.contributor.buuauthorGÜLLÜLÜ, MUSTAFA
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı.
dc.contributor.orcid0000-0002-0342-9692
dc.contributor.orcid0000-0002-5665-7402
dc.contributor.researcheridAAJ-8220-2020
dc.contributor.researcheridAAH-4002-2021
dc.contributor.researcheridHIG-9032-2022
dc.contributor.researcheridEJA-1761-2022
dc.contributor.researcheridCPX-5894-2022
dc.contributor.researcheridEHM-7377-2022
dc.contributor.researcheridEUF-5229-2022
dc.contributor.researcheridJGS-9425-2023
dc.date.accessioned2024-06-24T10:13:25Z
dc.date.available2024-06-24T10:13:25Z
dc.date.issued2021-04-01
dc.description.abstractBackground: The X-linked Fabry disease (FD) with lysosomal storage of globotriaosylceramide (Gb3) due to alpha-galactosidase deficiency contributes to nephropathy consisting of proteinuria and renal failure eventually. Early initiation of the enzyme replacement therapy promises favorable renal outcomes. With the importance of early diagnosis, we screened FD among proteinuric patients in whom biopsy findings revealed Fabry nephropathy.Methods: Patients with light microscopic biopsy findings of vacuolated cells, focal and/or segmental glomerular sclerosis, tubular atrophy, and interstitial fibrosis were not associated with particular etiology, the presence of acro-paresthesia, angiokeratomas, and cornea verticillata, stroke history younger than 50 years, family history of renal failure with no cardiovascular risk factors were screened. Fifty-three of 308 consecutive adult patients (45.34 +/- 15.23 years old, 60.1% male) who underwent renal biopsy because of proteinuria were enrolled in the study. Screening for FD was performed by assessing alpha-Gal A activity in dried blood spots (DBS) for males and by genetic testing for females.Results: Fifty-three patients (39.94 +/- 11.97 years, 69.8% male) who underwent renal biopsy were screened. Laboratory findings revealed mean serum creatinine of 1.44 +/- 1.06 mg/dL, mean estimated glomerular filtration rate of 78.31 +/- 39.89 mL/min/1.73 m(2), and mean proteinuria of 4.32 +/- 3 g/day, whereas the females genetic screening was negative. Two of 37 males had low enzyme activity (<0.1 micmol/L/h) and confirmed FD by genetic analysis in whom one had a novel mutation of GLA gene (c.(1047G>A) p.(Trp349*)).Conclusion: It is worth noting that FD screening in patients with proteinuria, in whom vacuolated cells, mesangial expansion, glomerulosclerosis, interstitial fibrosis, and tubular atrophy of unknown etiology, are present in the renal biopsy either with or without a family history of kidney disease.
dc.identifier.doi10.5152/turkjnephrol.2021.4709
dc.identifier.eissn2667-4440
dc.identifier.endpage170
dc.identifier.issue2
dc.identifier.startpage165
dc.identifier.urihttps://doi.org/10.5152/turkjnephrol.2021.4709
dc.identifier.urihttps://turkjnephrol.org/en/screening-for-fabry-disease-in-patients-who-underwent-renal-biopsy-and-identification-of-a-novel-mutation-136944
dc.identifier.urihttps://hdl.handle.net/11452/42268
dc.identifier.volume30
dc.identifier.wos000667482700011
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherAves
dc.relation.journalTurkish Journal of Nephrology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectEnzyme replacement therapy
dc.subjectChronic kidney-disease
dc.subjectAgalsidase alpha
dc.subjectNatural-history
dc.subjectPathology
dc.subjectDialysis
dc.subjectNephropathy
dc.subjectDiagnosis
dc.subjectProteinuria
dc.subjectPrevalence
dc.subjectAlpha-galactosidase
dc.subjectFabry disease
dc.subjectFabry nephropathy
dc.subjectRenal biopsy
dc.subjectUrology & nephrology
dc.titleScreening for fabry disease in patients who underwent renal biopsy and identification of a novel mutation
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationbd386ce4-0765-45b7-9a09-c10b5eca584a
relation.isAuthorOfPublicatione0f20ddb-a439-4c4a-b87e-d468370abf60
relation.isAuthorOfPublication4ebeed3e-c57f-4154-971b-7fad0fef4ceb
relation.isAuthorOfPublication3b0ea0d7-f953-4c53-9e92-e260b04f90b4
relation.isAuthorOfPublicationa096c377-129d-4ccb-94eb-205aaea33a01
relation.isAuthorOfPublication3483aae5-153f-4555-aa02-81efd2ace822
relation.isAuthorOfPublication47f5ec68-c479-4f62-9aed-37ba604a689c
relation.isAuthorOfPublication.latestForDiscoverybd386ce4-0765-45b7-9a09-c10b5eca584a

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Oruç_vd_2021_2.pdf
Size:
669.47 KB
Format:
Adobe Portable Document Format

Collections